Vertex Finally Inks Orkambi Deal In England
Stalemate Over As Parties Agree Deal That Also Includes Symkevi And Kalydeco
Vertex has finally managed to reach an agreement to bring its cystic fibrosis drugs Orkambi and Symkevi to patients in England, which constitutes an important slice of what is the second biggest market for the drugs.
